| Patent(s) and the Corresponding Patented Drug(s) |
Top |
| World Intellectual Property Organization (WIPO) |
| Patent ID |
WO2012053606 |
| Title |
Arylaminoheterocyclic Carboxamide Compound. |
| Applicant(s) |
Astellas Pharma Inc |
| Representative Drug(s) |
D0MX7B |
Drug Info
|
N.A. |
[1] |
| Patent ID |
WO2008139161 |
| Title |
Oxazole Tyrosine Kinase Inhibitors. |
| Abstract |
The invention provides a compound which is an amide of the formula (1), or a salt, solvate, N-oxide or tautomer thereof; wherein: a is 0 or 1; b is 0 or 1 : provided that the sum of a and b is 0 or 1; T is O or NH Ar1 is a monocyclic or bicyclic 5- to 10-membered aryl or heteroaryl group containing up to 4 heteroatoms selected from O, N and S, and being optionally substituted by one or more substituents R1; Ar2 Js a monocyclic or bicyclic 5- to 10-membered aryl or heteroaryl group containing up to 4 heteroatoms selected from O, N and S and being optionally substituted by one or more substituents R2; and R1 and R2 are as defined in the claims. The compounds are inhibitors of kinases and in particular FLT3, FLT4 and Aurora kinases. |
| Applicant(s) |
Sareum Limited |
| United States Patent and Trademark Office (USPTO) |
| Patent ID |
US9029386 |
| Title |
Inhibitors of Kinase Activity. |
| Applicant(s) |
Ym Biosciences Australia Pty |
| Representative Drug(s) |
D0AK1F |
Drug Info
|
N.A. |
[1] |
| Patent ID |
US20130137660 |
| Title |
Inhibitors of Kinase Activity. |
| Applicant(s) |
Ym Biosciences Australia Pty |
| Representative Drug(s) |
D0AK1F |
Drug Info
|
N.A. |
[1] |
